Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Smoking Cessation 1Ovarian Neoplasms 1Neoplasms 1Mental Disorders 1Hematopoietic and Lymphoid System Neoplasm 1Hematologic Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 6fludarabine 4Standard of Care 4Practice Guidelines as Topic 3Mycophenolic Acid 3GSK2636771 3venetoclax 2trametinib 2talquetamab 2osimertinib 2dabrafenib 2X-Rays 2Whole-Body Irradiation 2Thiotepa 2Tacrolimus 2Specimen Handling 2Patient Navigation 2Methods 2Mesna 2Melphalan 2Magnetic Resonance Spectroscopy 2Filgrastim 2Educational Status 2Early Intervention, Educational 2Biopsy 2ulixertinib 1trastuzumab biosimilar HLX02 1thymoglobulin 1sapanisertib 1ruxolitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Behavior Therapy × 30 days × Clear all
NCT04776941 2026-06-02

Expressive Writing for the Management of Stress in Cancer Survivors

M.D. Anderson Cancer Center

Phase NA Recruiting
414 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡